George Scangos, leader of infectious disease drugmaker Vir Biotechnology and one of the industry’s more high-profile chief executives, is retiring in April, the company said Wednesday.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,